Across TCGA patient cohorts, RPL22P3 RNA expression is significantly associated with the protein abundance of many other proteins, with 9,502 significant associations in total. CCRCC shows the largest number of these associations.

The most reproducible RPL22P3-associated proteins across cancer lineages are PRPF19, RBM15, and CDC5L. Each is linked with RPL22P3 in more than 3 cancer types. Because this analysis shows association rather than direction, both RPL22P3-to-partner and partner-to-RPL22P3 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL22P3→partner) and Y-score (partner→RPL22P3) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner protein	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BRCA	PRPF19 →	+0.220	+0.619	<.001	<.001	3	4
GBM	RBM15 →	+0.194	+0.320	<.001	.002	3	4
GBM	CDC5L →	+0.228	+0.400	.002	.004	3	4
GBM	AKAP8L →	+0.267	+0.567	.001	<.001	3	4
LSCC	RBM39_S97 →	+0.259	+0.344	.001	.001	3	3
OV	CHAMP1_S416 →	+0.542	+1.106	.003	<.001	3	3

Each partner links to its Q-omics profile. Showing the 6 strongest of 9,502 associations by consensus.

Exploration

RPL22P3 survival (RNA) · tumor vs normal (RNA) · all RPL22P3 data types